Endari 5 GM Powder for Oral Solution
- RxCUI
- 1928941
- RxNorm name
- Endari 5 GM Powder for Oral Solution
- Display name
- Endari 5 GM Powder for Oral Solution
- Full name
- Endari 5 GM Powder for Oral Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Endari | GLUTAMINE | Emmaus Medical, Inc. | d5a783f4-12ef-4326-8faa-40018e45ba3b | 2025-06-20 | Adverse reactions | 1928941 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d5a783f4-12ef-4326-8faa-40018e45ba3b | Endari 5 GM Powder for Oral Solution [PSN] · glutamine 5000 MG Powder for Oral Solution [Endari] [SBD] · Endari 5000 MG Powder for Oral Solution [SY] | 3 | 10 | These highlights do not include all the information needed to use ENDARI™ safely and effectively. See full prescribing information for ENDARI. ENDARI (L-glutamine oral powder ) Initial U.S. Approval: 2017 | 20250620 |